desacetyl cephapirin has been researched along with lenvatinib in 1 studies
| Studies (desacetyl cephapirin) | Trials (desacetyl cephapirin) | Recent Studies (post-2010) (desacetyl cephapirin) | Studies (lenvatinib) | Trials (lenvatinib) | Recent Studies (post-2010) (lenvatinib) |
|---|---|---|---|---|---|
| 6 | 1 | 2 | 975 | 112 | 946 |
| Protein | Taxonomy | desacetyl cephapirin (IC50) | lenvatinib (IC50) |
|---|---|---|---|
| Proto-oncogene tyrosine-protein kinase receptor Ret | Homo sapiens (human) | 0.0162 | |
| Platelet-derived growth factor receptor beta | Homo sapiens (human) | 0.039 | |
| Platelet-derived growth factor receptor alpha | Homo sapiens (human) | 0.051 | |
| Vascular endothelial growth factor receptor 1 | Homo sapiens (human) | 0.022 | |
| Kinesin-1 heavy chain | Homo sapiens (human) | 0.01 | |
| Vascular endothelial growth factor receptor 3 | Homo sapiens (human) | 0.0052 | |
| Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | 0.0035 | |
| Nuclear receptor coactivator 4 | Homo sapiens (human) | 0.01 | |
| Coiled-coil domain-containing protein 6 | Homo sapiens (human) | 0.01 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alcaro, S; Ambrosio, FA; Artese, A; Bagetta, D; Carta, F; Catalano, R; Costa, G; Lupia, A; Maruca, A; Moraca, F; Ortuso, F; Rocca, R; Romeo, I; Supuran, CT; Vullo, D | 1 |
1 other study(ies) available for desacetyl cephapirin and lenvatinib
| Article | Year |
|---|---|
A computer-assisted discovery of novel potential anti-obesity compounds as selective carbonic anhydrase VA inhibitors.
Topics: Anti-Obesity Agents; Carbonic Anhydrase I; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Computer-Aided Design; Drug Discovery; Drug Repositioning; Humans; Molecular Docking Simulation; Obesity | 2019 |